NUVA Stock Recent News

NuVasive, Inc. (NASDAQ:NUVA ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Juliet Cunningham - Vice President-Investor Relations Chris Barry - Chief Executive Officer Matt Harbaugh - Chief Financial Officer Conference Call Participants Matt Miksic - Barclays Joshua Jennings - Cowen Vikramjeet Chopra - Wells Fargo Joanne Wuensch - Citibank Samuel Brodovsky - Truist Shagun Singh - RBC David Saxon - Needham & Company Jeffrey Johnson - Baird Matthew Taylor - Jefferies Allen Gong - JPMorgan Matthew O'Brien - Piper Sandler Matthew Blackman - Stifel Operator Good day, ladies and gentlemen, and welcome to the NuVasive Third Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to introduce your host for today's call, Miss.

NuVasive (NUVA) delivered earnings and revenue surprises of 1.89% and 0.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

The share price declined by ~46% since the beginning of the coronavirus pandemic crisis in 2020. Revenues returned to the growth path thanks to high R&D expenses and acquisitions.

SAN DIEGO , Oct. 25, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter financial results on Wednesday, November 9, 2022, after the market close. NuVasive will hold a conference call on Wednesday, November 9, 2022, at 4:30 p.m.

NuVasive's (NUVA) Q2 revenues outpaced the consensus mark with strong sales across U.S. Spinal Hardware and Surgical Support businesses.

NuVasive, Inc. (NASDAQ:NUVA ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Juliet Cunningham – Vice President-Investor Relations Chris Barry – Chief Executive Officer Matt Harbaugh – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen Vik Chopra – Wells Fargo Joanne Wuensch – Citi Shagun Singh – RBC Capital Markets Allen Gong – JPMorgan Rich Newitter – Truist Securities Drew Ranieri – Morgan Stanley Jason Wittes – Loop Capital Matt Miksic – Barclays Operator Good day, ladies and gentlemen, and welcome to the NuVasive Second Quarter 2022 Earnings Conference Call. I would now like to introduce your host for today's call, Ms.

NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NUVA vs. RMD: Which Stock Is the Better Value Option?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Robust sales performance across all U.S. product lines drove NuVasive's (NUVA) Q1 top line.